Development and validation of the International Hidradenitis Suppurativa Severity Score System ( IHS 4), a novel dynamic scoring system to assess HS severity
Top Cited Papers
- 30 October 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 177 (5), 1401-1409
- https://doi.org/10.1111/bjd.15748
Abstract
A validated tool for the dynamic severity assessment of hidradenitis suppurativa (HS) is lacking. The aim of this study was to develop and validate such a novel scoring system.A Delphi voting procedure was conducted among the members of the European Hidradenitis Suppurativa Foundation (EHSF) to achieve consensus towards an initial HS Severity Score System (HS4). Strengths and weaknesses of HS4 were examined by a multicenter prospective study. Multivariate logistic regression, discriminant analysis and receiver operating characteristic curves and examination for correlation (Spearman's rho) and agreement (Cohen's kappa) with existing scores were engaged to recognize the variables for a new International HS Severity Scoring System (IHS4) that was established by a 2(nd) Delphi round.Consensus HS4 was based on the number of skin lesions, the number of skin areas involved and the Dermatology Life Quality Index and was evaluated by a sample of 236 patients from 11 centers. Subsequently, a multivariate regression model calculated adjusted odds ratios for several clinical signs. Nodules, abscesses and draining tunnels resulted as the scoring variables. Three candidate scores were presented to the 2nd Delphi round. The resulting IHS4 score is calculated by the number of nodules (multiplied by 1) + the number of abscesses (multiplied by 2) + the number of draining tunnels (multiplied by 4). A total score of 3 or less signifies mild, 4-10 signifies moderate and 11 or higher signifies severe disease. Cohen's kappa was fair (κ=0.317) compared with Hurley classification and moderate (κ=0.493) compared with Expert Opinion. Correlation was good (rho>0.6) with Hurley classification, Expert Opinion, Physician's Global Assessment and Modified Sartorius score and moderate for Dermatology Life Quality Index (rho=0.356).The novel IHS4 is a validated tool to dynamically assess HS severity and can be used both in real-life and the clinical trials setting. This article is protected by copyright. All rights reserved.Keywords
Funding Information
- European Academy of Dermatology and Venereology (EADV-2015-023)
This publication has 21 references indexed in Scilit:
- Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the processBritish Journal of Dermatology, 2016
- Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativaReviews in Endocrine and Metabolic Disorders, 2016
- Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studiesBritish Journal of Dermatology, 2015
- Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease EvaluationDermatology, 2015
- European S1 guideline for the treatment of hidradenitis suppurativa/acne inversaJournal of the European Academy of Dermatology and Venereology, 2015
- Adalimumab for the Treatment of Moderate to Severe Hidradenitis SuppurativaAnnals of Internal Medicine, 2012
- Interobserver variability of clinical scores in hidradenitis suppurativa is lowBritish Journal of Dermatology, 2010
- Comorbidities of hidradenitis suppurativa (acne inversa)Dermato-Endocrinology, 2010
- Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesityBritish Journal of Dermatology, 2009
- What causes hidradenitis suppurativa?Experimental Dermatology, 2008